Easywell Biomedicals, Inc.
1799.TWO
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.57B
Close$
Share Statistics
| Market cap | $3.57 Billion |
|---|---|
| Enterprise Value | $3.59 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.59 |
| Beta | -0.12 |
| Outstanding Shares | 120,222,000 |
Return
| Return on Equity | -2.29% |
|---|---|
| Return on Assets | -1.26% |
| Return on Invested Capital | -2.44% |
Valuation & Multiples
| P/E Ratio | -220 |
|---|---|
| PEG | 295.1 |
| Price to Sales | 4.77 |
| Price to Book Ratio | 4.77 |
| Enterprise Value to Revenue | 4.49 |
| Enterprise Value to EBIT | -143.45 |
| Enterprise Value to Net Income | -221 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.54 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Easywell Biomedicals, Inc.
3,118 employees
CEO: Ai Ping Lee Easywell Biomedicals, Inc., together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in America. It operates through Drug Development and Other segments. The c...